Evidence map›Paper›PMID 35099603›Full record

ArticleEuropean radiology2022

Diagnostic Accuracy of 2-[

Ali Rashidi, Lucia Baratto, Ashok Joseph Theruvath, Elton Benjamin Greene, K Elizabeth Hawk, Rong Lu, Michael P Link, Sheri L Spunt, Heike E Daldrup-Link

Open access · greenAbstract read
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Whole-Body MRI VersusCancers · 2026
    Article
  3. Article
  4. Article
  5. Melanin-targeted [European journal of nuclear medicine and molecular imaging · 2023
    Article
  6. Head-to-Head Comparison between FDG andDiagnostics (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Comparison of whole-body DW-MRI with 2-[European journal of nuclear medicine and molecular imaging · 2023
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ali RashidiDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA.
Lucia BarattoDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA.
Ashok Joseph TheruvathDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA.
Elton Benjamin GreeneDepartment of Radiology, Pediatric Radiology, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, CA, USA.
K Elizabeth HawkDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA.
Rong LuQuantitative Sciences Unit, School of Medicine, Stanford University, Stanford, CA, USA.
Michael P LinkDepartment of Pediatrics, Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Sheri L SpuntDepartment of Pediatrics, Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Heike E Daldrup-LinkDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA. H.E.Daldrup-Link@stanford.edu.
Stanford University · USLucile Packard Children's Hospital · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Advanced Imaging Tools to Assess Cancer Therapeutics in Pediatric PatientsR01CA269231 · NCI · STANFORD UNIVERSITY · PI Heike Elizabeth Daldrup-Link · 2022 to 2026
$3.5M
Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT ScansR01HD081123 · NICHD · STANFORD UNIVERSITY · PI DALDRUP-LINK, HEIKE ELIZABETH · 2015 to 2019
$2.5M
NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA269231NICHD NIH HHS R01 HD081123
6 · The paper itself

Abstract

objectivesTo compare the diagnostic accuracy of 2-[

methodsIn this cross-sectional single-center institutional review board-approved study, we investigated twenty-three children and young adults (mean age, 16.8 years ± 5.1 [standard deviation]; age range, 7-25 years; 16 males, 7 females) with 925 bone marrow metastases who underwent 66 simultaneous 2-[

resultsThe reviewers detected 884 (884/925, 95.5%) bone marrow metastases on 2-[

conclusionsBoth 2-[ KEY POINTS: • DW-MRI and 2-[

Indexed as

Bone Marrow NeoplasmsBone NeoplasmsAdolescentAdultChildCross-Sectional StudiesDiffusion Magnetic Resonance ImagingFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMalePositron-Emission TomographyRadiopharmaceuticalsSensitivity and SpecificityTomography, X-Ray ComputedFluorodeoxyglucose F18Radiopharmaceuticals2-[18F]FDG-PETBone marrow metastasesChildrenDW-MRIPET/MRI

Identifiers

PMID35099603
PMCPMC9232918
OpenAlexW4210300021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.